APO RESEARCH · REPORT
Phototherapy Treatment
Phototherapy is a type of medical treatment that involves exposure to fluorescent light bulbs or other sources of light like halogen lights, sunlight, and light emitting diodes (LEDs) to treat certain medical conditions.
Product & engineering
Understand the product.
Phototherapy is a type of medical treatment that involves exposure to fluorescent light bulbs or other sources of light like halogen lights, sunlight, and light emitting diodes (LEDs) to treat certain medical conditions.
This report is about Phototherapy device.
Selected research
Market Outlook & Growth Opportunities
Global Phototherapy Treatment Market Outlook and Growth Opportunities 2026
Market perspective
Phototherapy is a type of medical treatment that involves exposure to fluorescent light bulbs or other sources of light like halogen lights, sunlight, and light emitting diodes (LEDs) to treat certain medical conditions.
This report is about Phototherapy device.
Global key players of Phototherapy Treatment include GE Healthcare, Atom Medical, Draeger, Herbert Waldmann, Natus Medical, Daavlin, Beurer and National Biological, etc. Top three players occupy for a share about 19%. North America is the largest market, with a share about 31%, followed by Europe and Asia-Pacific. In terms of product, LED Phototherapy Treatment is the largest segment, with a share over 59%. In terms of application, Hospital and Clinic is the largest market, with a share over 84%.
Read the full market overview
This report provides an overview of the global Phototherapy Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Phototherapy Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Phototherapy Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Phototherapy Treatment market.
Phototherapy Treatment Segment by Company
GE Healthcare
Atom Medical
Draeger
Herbert Waldmann
Natus Medical
Daavlin
Beurer
National Biological
DAVID
Solarc Systems Inc.
UVBioTek
MTTS Asia
Nice Neotech
Phototherapy Treatment Segment by Type
Conventional
LED
Fiberoptic
Phototherapy Treatment Segment by Application
Hospital & Clinic
Home
Phototherapy Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Phototherapy Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Phototherapy Treatment key companies, revenue, market share, and recent developments.
3. To split the Phototherapy Treatment breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Phototherapy Treatment market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Phototherapy Treatment significant trends, drivers, influence factors in global and regions.
6. To analyze Phototherapy Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phototherapy Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Phototherapy Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phototherapy Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Phototherapy Treatment industry.
Chapter 3: Detailed analysis of Phototherapy Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Phototherapy Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Phototherapy Treatment in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Conventional
- LED
- Fiberoptic
Applications
- Hospital & Clinic
- Home
Companies covered
- GE Healthcare
- Atom Medical
- Draeger
- Herbert Waldmann
- Natus Medical
- Daavlin
- Beurer
- National Biological
- DAVID
- Solarc Systems Inc.
- UVBioTek
- MTTS Asia
- Nice Neotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Phototherapy Treatment Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Phototherapy Treatment Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Phototherapy Treatment Market Dynamics
- 2.1 Phototherapy Treatment Industry Trends
- 2.2 Phototherapy Treatment Industry Drivers
- 2.3 Phototherapy Treatment Industry Opportunities and Challenges
- 2.4 Phototherapy Treatment Industry Restraints
3 Phototherapy Treatment Market by Company
- 3.1 Global Phototherapy Treatment Company Revenue Ranking in 2025
- 3.2 Global Phototherapy Treatment Revenue by Company (2021-2026)
- 3.3 Global Phototherapy Treatment Company Ranking (2024-2026)
- 3.4 Global Phototherapy Treatment Company Manufacturing Base and Headquarters
- 3.5 Global Phototherapy Treatment Company Product Type and Application
- 3.6 Global Phototherapy Treatment Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Phototherapy Treatment Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Phototherapy Treatment Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Phototherapy Treatment Market by Type
- 4.1 Phototherapy Treatment Type Introduction
- 4.1.1 Conventional
- 4.1.2 LED
- 4.1.3 Fiberoptic
- 4.2 Global Phototherapy Treatment Sales Value by Type
- 4.2.1 Global Phototherapy Treatment Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Phototherapy Treatment Sales Value by Type (2021-2032)
- 4.2.3 Global Phototherapy Treatment Sales Value Share by Type (2021-2032)
5 Phototherapy Treatment Market by Application
- 5.1 Phototherapy Treatment Application Introduction
- 5.1.1 Hospital & Clinic
- 5.1.2 Home
- 5.2 Global Phototherapy Treatment Sales Value by Application
- 5.2.1 Global Phototherapy Treatment Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Phototherapy Treatment Sales Value by Application (2021-2032)
- 5.2.3 Global Phototherapy Treatment Sales Value Share by Application (2021-2032)
6 Phototherapy Treatment Regional Value Analysis
- 6.1 Global Phototherapy Treatment Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Phototherapy Treatment Sales Value by Region (2021-2032)
- 6.2.1 Global Phototherapy Treatment Sales Value by Region: 2021-2026
- 6.2.2 Global Phototherapy Treatment Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Phototherapy Treatment Sales Value (2021-2032)
- 6.3.2 North America Phototherapy Treatment Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Phototherapy Treatment Sales Value (2021-2032)
- 6.4.2 Europe Phototherapy Treatment Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Phototherapy Treatment Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Phototherapy Treatment Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Phototherapy Treatment Sales Value (2021-2032)
- 6.6.2 South America Phototherapy Treatment Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Phototherapy Treatment Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Phototherapy Treatment Sales Value Share by Country, 2025 VS 2032
7 Phototherapy Treatment Country-level Value Analysis
- 7.1 Global Phototherapy Treatment Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Phototherapy Treatment Sales Value by Country (2021-2032)
- 7.2.1 Global Phototherapy Treatment Sales Value by Country (2021-2026)
- 7.2.2 Global Phototherapy Treatment Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.7.2 France Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.14.2 China Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.17.2 India Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Phototherapy Treatment Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Phototherapy Treatment Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Phototherapy Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 GE Healthcare
- 8.1.1 GE Healthcare Company Information
- 8.1.2 GE Healthcare Business Overview
- 8.1.3 GE Healthcare Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 8.1.4 GE Healthcare Phototherapy Treatment Product Portfolio
- 8.1.5 GE Healthcare Recent Developments
- 8.2 Atom Medical
- 8.2.1 Atom Medical Company Information
- 8.2.2 Atom Medical Business Overview
- 8.2.3 Atom Medical Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 8.2.4 Atom Medical Phototherapy Treatment Product Portfolio
- 8.2.5 Atom Medical Recent Developments
- 8.3 Draeger
- 8.3.1 Draeger Company Information
- 8.3.2 Draeger Business Overview
- 8.3.3 Draeger Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 8.3.4 Draeger Phototherapy Treatment Product Portfolio
- 8.3.5 Draeger Recent Developments
- 8.4 Herbert Waldmann
- 8.4.1 Herbert Waldmann Company Information
- 8.4.2 Herbert Waldmann Business Overview
- 8.4.3 Herbert Waldmann Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 8.4.4 Herbert Waldmann Phototherapy Treatment Product Portfolio
- 8.4.5 Herbert Waldmann Recent Developments
- 8.5 Natus Medical
- 8.5.1 Natus Medical Company Information
- 8.5.2 Natus Medical Business Overview
- 8.5.3 Natus Medical Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 8.5.4 Natus Medical Phototherapy Treatment Product Portfolio
- 8.5.5 Natus Medical Recent Developments
- 8.6 Daavlin
- 8.6.1 Daavlin Company Information
- 8.6.2 Daavlin Business Overview
- 8.6.3 Daavlin Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 8.6.4 Daavlin Phototherapy Treatment Product Portfolio
- 8.6.5 Daavlin Recent Developments
- 8.7 Beurer
- 8.7.1 Beurer Company Information
- 8.7.2 Beurer Business Overview
- 8.7.3 Beurer Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 8.7.4 Beurer Phototherapy Treatment Product Portfolio
- 8.7.5 Beurer Recent Developments
- 8.8 National Biological
- 8.8.1 National Biological Company Information
- 8.8.2 National Biological Business Overview
- 8.8.3 National Biological Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 8.8.4 National Biological Phototherapy Treatment Product Portfolio
- 8.8.5 National Biological Recent Developments
- 8.9 DAVID
- 8.9.1 DAVID Company Information
- 8.9.2 DAVID Business Overview
- 8.9.3 DAVID Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 8.9.4 DAVID Phototherapy Treatment Product Portfolio
- 8.9.5 DAVID Recent Developments
- 8.10 Solarc Systems Inc.
- 8.10.1 Solarc Systems Inc. Company Information
- 8.10.2 Solarc Systems Inc. Business Overview
- 8.10.3 Solarc Systems Inc. Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 8.10.4 Solarc Systems Inc. Phototherapy Treatment Product Portfolio
- 8.10.5 Solarc Systems Inc. Recent Developments
- 8.11 UVBioTek
- 8.11.1 UVBioTek Company Information
- 8.11.2 UVBioTek Business Overview
- 8.11.3 UVBioTek Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 8.11.4 UVBioTek Phototherapy Treatment Product Portfolio
- 8.11.5 UVBioTek Recent Developments
- 8.12 MTTS Asia
- 8.12.1 MTTS Asia Company Information
- 8.12.2 MTTS Asia Business Overview
- 8.12.3 MTTS Asia Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 8.12.4 MTTS Asia Phototherapy Treatment Product Portfolio
- 8.12.5 MTTS Asia Recent Developments
- 8.13 Nice Neotech
- 8.13.1 Nice Neotech Company Information
- 8.13.2 Nice Neotech Business Overview
- 8.13.3 Nice Neotech Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 8.13.4 Nice Neotech Phototherapy Treatment Product Portfolio
- 8.13.5 Nice Neotech Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst